Par

Portman Ridge Finance Corporation Announces First Quarter 2024 Financial Results

Retrieved on: 
Mercoledì, Maggio 8, 2024

NEW YORK, May 08, 2024 (GLOBE NEWSWIRE) -- Portman Ridge Finance Corporation (Nasdaq: PTMN) (the “Company” or “Portman Ridge”) announced today its financial results for the first quarter ended March 31, 2024.

Key Points: 
  • Continued Share Repurchase Program: Total of 51,015 Shares for an Aggregate Cost of Approximately $1.0 Million Repurchased During the First Quarter; Accretive to NAV by $0.02 Per Share
    NEW YORK, May 08, 2024 (GLOBE NEWSWIRE) -- Portman Ridge Finance Corporation (Nasdaq: PTMN) (the “Company” or “Portman Ridge”) announced today its financial results for the first quarter ended March 31, 2024.
  • Net investment income ("NII") for the first quarter of 2024 was $6.2 million ($0.67 per share) as compared to $11.2 million ($1.18 per share) in the fourth quarter of 2023.
  • Declared stockholder distribution of $0.69 per share for the second quarter of 2024, payable on May 31, 2024, to stockholders of record at the close of business on May 21, 2024.
  • Ted Goldthorpe, Chief Executive Officer of Portman Ridge, stated, “Following the strong earnings we saw in 2023, Portman Ridge is off to a solid start in 2024, ending the first quarter with net deployment and a robust pipeline.

Susan G. Komen® Peoria MORE THAN PINK Walk Raises Funds for Breast Cancer Patient Care Services

Retrieved on: 
Lunedì, Aprile 15, 2024

Susan G. Komen ®, the world’s leading breast cancer organization, will hold the Susan G. Komen Peoria MORE THAN PINK Walk on Saturday, May 11, 2024, at Metro Centre.

Key Points: 
  • Susan G. Komen ®, the world’s leading breast cancer organization, will hold the Susan G. Komen Peoria MORE THAN PINK Walk on Saturday, May 11, 2024, at Metro Centre.
  • This signature event enables Komen to raise critical funds that provide direct support to breast cancer patients, fund groundbreaking research, empower health equity initiatives nationwide, and advocate for change at both the state and federal government levels.
  • “We are excited to host the annual Peoria MORE THAN PINK Walk this year and provide a community for all individuals impacted by breast cancer.
  • Register today and join us as we celebrate survivors and those living with breast cancer as well as honor loved ones lost to the disease.

Par Pharmaceutical Issues Voluntary Nationwide Recall of Seven Lots of Treprostinil Injection Due to Potential for Silicone Particulates in the Product Solution

Retrieved on: 
Lunedì, Aprile 22, 2024

The lots were distributed nationwide to wholesalers and hospitals from June 16, 2022 through August 7, 2023.

Key Points: 
  • The lots were distributed nationwide to wholesalers and hospitals from June 16, 2022 through August 7, 2023.
  • If you have further distributed the recalled product, please notify your accounts or any additional locations which may have received the recalled product.
  • For information regarding the recall process, call Inmar, Inc. at 1-855-410-3565 Monday through Friday between the hours of 9 am and 5 pm EST.
  • For medical or technical product information or to report a product complaint or adverse event please call 1-800-828-9393.

Par Pacific Announces First Quarter 2024 Earnings Release and Conference Call Schedule

Retrieved on: 
Martedì, Aprile 9, 2024

HOUSTON, April 09, 2024 (GLOBE NEWSWIRE) -- Par Pacific Holdings, Inc. (NYSE: PARR) (“Par Pacific”) today announced that it will release its first quarter 2024 results after the New York Stock Exchange closes on Monday, May 6, 2024.

Key Points: 
  • HOUSTON, April 09, 2024 (GLOBE NEWSWIRE) -- Par Pacific Holdings, Inc. (NYSE: PARR) (“Par Pacific”) today announced that it will release its first quarter 2024 results after the New York Stock Exchange closes on Monday, May 6, 2024.
  • This release will be followed by a conference call for investors on Tuesday, May 7, 2024 at 9:00 a.m. Central Time (10:00 a.m. Eastern).
  • The full text of the release will be available on Par Pacific’s website at http://www.parpacific.com .
  • To access the live audio webcast and related presentation materials, please visit the Investors section of Par Pacific's website at http://www.parpacific.com .

Portman Ridge Finance Corporation Announces Fourth Quarter and Full Year 2023 Financial Results

Retrieved on: 
Mercoledì, Marzo 13, 2024

NEW YORK, March 13, 2024 (GLOBE NEWSWIRE) -- Portman Ridge Finance Corporation (Nasdaq: PTMN) (the “Company” or “Portman Ridge”) announced today its financial results for the fourth quarter and full year ended December 31, 2023.

Key Points: 
  • Reports Strong Year-Over-Year Performance with Total Investment Income of $76.3 Million, an Increase of 9.6% and Net Investment Income of $34.8 Million
    NEW YORK, March 13, 2024 (GLOBE NEWSWIRE) -- Portman Ridge Finance Corporation (Nasdaq: PTMN) (the “Company” or “Portman Ridge”) announced today its financial results for the fourth quarter and full year ended December 31, 2023.
  • Total investment income for the fourth quarter of 2023 was $17.8 million, a decrease of $0.8 million as compared to $18.6 million for the fourth quarter of 2022 and a decrease of $0.8 million as compared to $18.6 million for the third quarter of 2023.
  • Core investment income1, excluding the impact of purchase price accounting, for the fourth quarter of 2023 was $17.7 million, unchanged from the fourth quarter of 2022 and a decrease of $0.6 million as compared to $18.3 million for the third quarter of 2023.
  • The increase in NII in the fourth quarter of 2023 was the result of a one-time expense reimbursement from the Company’s investment adviser.

Par Pharmaceutical Issues Voluntary Nationwide Recall of One Lot of Treprostinil Injection Due to Potential for Silicone Particulates in the Product Solution

Retrieved on: 
Martedì, Marzo 12, 2024

The product is being recalled due to the potential for the presence of silicone particulates in the product solution.

Key Points: 
  • The product is being recalled due to the potential for the presence of silicone particulates in the product solution.
  • Administration of an injectable product that contains particulate matter may result in local irritation or swelling in response to the foreign material.
  • Treprostinil Injection 20mg/20mL (1mg/mL) is distributed in 20mL multidose vials as sterile solutions in water for injection, individually packaged in cartons under NDC #42023-206-01.
  • If you have further distributed the recalled product, please notify your accounts or any additional locations which may have received the recalled product.

Par Pacific Reports Fourth Quarter and Record 2023 Results

Retrieved on: 
Martedì, Febbraio 27, 2024

HOUSTON, Feb. 27, 2024 (GLOBE NEWSWIRE) -- Par Pacific Holdings, Inc. (NYSE: PARR) (“Par Pacific” or the “Company”) today reported its financial results for the fourth quarter and twelve months ended December 31, 2023.

Key Points: 
  • HOUSTON, Feb. 27, 2024 (GLOBE NEWSWIRE) -- Par Pacific Holdings, Inc. (NYSE: PARR) (“Par Pacific” or the “Company”) today reported its financial results for the fourth quarter and twelve months ended December 31, 2023.
  • Fourth quarter 2023 Adjusted Net Income was $65.2 million, compared to $132.8 million in the fourth quarter of 2022.
  • Fourth quarter 2023 Adjusted EBITDA was $122.0 million, compared to $174.9 million in the fourth quarter of 2022.
  • Refining segment Adjusted EBITDA was $106.5 million in the fourth quarter of 2023, compared to $146.4 million in the fourth quarter of 2022.

Par Pacific Announces CEO Transition Plans

Retrieved on: 
Martedì, Febbraio 27, 2024

William Pate to step down as Chief Executive Officer; will remain Director

Key Points: 
  • William Pate to step down as Chief Executive Officer; will remain Director
    HOUSTON, Feb. 27, 2024 (GLOBE NEWSWIRE) -- Par Pacific Holdings, Inc. (NYSE: PARR) (“Par Pacific”) today announced a leadership transition effective as of the Company’s May 2024 shareholders’ meeting.
  • Monteleone has been with Par Pacific for more than a decade and has served in several leadership positions for the company.
  • Robert Silberman, Chairman of Par Pacific’s Board of Directors, said “Bill Pate has been the instrumental force behind Par Pacific’s success since its inception over 10 years ago.
  • I am very excited to continue working closely with the entire Par Pacific team to drive shareholder value over the next chapter of our growth.”

ProPetro Reports Financial Results for the Fourth Quarter and Full Year of 2023

Retrieved on: 
Mercoledì, Febbraio 21, 2024

ProPetro Holding Corp. ("ProPetro" or "the Company") (NYSE: PUMP) today announced financial and operational results for the fourth quarter and full year of 2023.

Key Points: 
  • ProPetro Holding Corp. ("ProPetro" or "the Company") (NYSE: PUMP) today announced financial and operational results for the fourth quarter and full year of 2023.
  • Net loss for the fourth quarter of 2023 includes $8 million of true-up depreciation related to changing the useful lives of certain equipment.
  • Net cash used in investing activities as shown on the statement of cash flows during the fourth quarter of 2023 was $71 million.
  • We have already seen our activity recover from the impacts we experienced in the fourth quarter of 2023.

Par Pacific Announces Fourth Quarter 2023 Earnings Release and Conference Call Schedule

Retrieved on: 
Mercoledì, Gennaio 31, 2024

HOUSTON, Jan. 31, 2024 (GLOBE NEWSWIRE) -- Par Pacific Holdings, Inc. (NYSE: PARR) (“Par Pacific”) today announced that it will release its fourth quarter 2023 results after the New York Stock Exchange closes on Tuesday, February 27, 2024.

Key Points: 
  • HOUSTON, Jan. 31, 2024 (GLOBE NEWSWIRE) -- Par Pacific Holdings, Inc. (NYSE: PARR) (“Par Pacific”) today announced that it will release its fourth quarter 2023 results after the New York Stock Exchange closes on Tuesday, February 27, 2024.
  • This release will be followed by a conference call for investors on Wednesday, February 28, 2024 at 9:00 a.m. Central Time (10:00 a.m. Eastern).
  • The full text of the release will be available on Par Pacific’s website at http://www.parpacific.com .
  • To access the live audio webcast and related presentation materials, please visit the Investors section of Par Pacific's website at http://www.parpacific.com .